EVOQ 543500

Evoq Remedies Share PriceEvoq Remedies

₹14.5
0.32 (2.26%)
As on 28 March, 2023 | 08:04 BSE: 543500 NSE: EVOQ

Evoq Remedies Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Evoq Remedies

Start SIP

Evoq Remedies Share Price

  • Over 1 Month 7.41%
  • Over 3 Month -3.33%
  • Over 6 Month -16.18%

Evoq Remedies Key Statistics

Evoq Remedies Investment Rating

  • Master Rating:
  • Evoq Remedies has an operating revenue of Rs. 39.13 Cr. on a trailing 12-month basis. An annual revenue growth of 67% is outstanding, Pre-tax margin of 9% is okay, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 78 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

N/A

Price Strength

Buyer Demand

Group Rank

Evoq Remedies Financials
IndicatorMar 2022
Total Revenue Annual Cr 17
Operating Expenses Annual Cr 15
Operating Profit Annual in Cr 1
Depreciation Cr 0
Interest Annual Cr 0
Tax Annual Cr 0
Net Profit Annual Cr 1

Evoq Remedies Technicals

EMA & SMA

Current Price
₹14.5
0.32 (2.26%)
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • 14.03
  • 50 Day
  • 14.2
  • 100 Day
  • 14.56
  • 200 Day
  • 14.87
  • 20 Day
  • 13.54
  • 50 Day
  • 14.13
  • 100 Day
  • 14.77
  • 200 Day
  • 14.64

Evoq Remedies Resistance and Support

PIVOT
₹14.15
Resistance
First Resistance 14.29
Second Resistance 14.4
Third Resistance 14.54
RSI 53.4
MFI 76.23
MACD 0.16
Support
First Resistance 14.04
Second Resistance 13.9
Third Resistance 13.79

Evoq Remedies Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 24,000 1,600,080 66.67
Week 16,000 1,400,000 87.5
1 Month 13,647 1,152,904 84.48
6 Month 14,742 1,161,222 78.77

Evoq Remedies Result Highlights

Evoq Remedies Synopsis

BSE-Medical-Ethical Drugs

Evoq Remedies belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 16.78 Cr. and Equity Capital is Rs. 13.60 Cr. for the Year ended 31/03/2022. Evoq Remedies Ltd. is a Public Limited Listed company incorporated on 24/02/2010 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24230GJ2010PLC059692 and registration number is 059692.
Market Cap 20
Sales 17
Shares in Float 0.35
No of funds
Yield
Book Value 0.85
U/D Vol ratio 1.3
LTDebt / Equity 1
Alpha 0.01
Beta 1.23

Evoq Remedies

Owner NameSep-22Mar-22
Promoters 73.53%73.53%
Individual Investors 24.56%23.06%
Others 1.91%3.41%

Evoq Remedies Management

Name Designation
Mr. Bhumishth Narendrabhai Patel Chairman & Managing Director
Mrs. Payal Bhumishth Patel Non Exe.Non Ind.Director
Mr. Tarunkumar Gunvantlal Patel Non Exe.Non Ind.Director
Mr. Pranav Manoj Vajani Independent Director
Mr. Digesh Mansukhlal Deshaval Independent Director

Evoq Remedies Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Evoq Remedies FAQs

What is Share Price of Evoq Remedies ?

Evoq Remedies share price is ₹14 As on 28 March, 2023 | 07:50

What is the Market Cap of Evoq Remedies ?

The Market Cap of Evoq Remedies is ₹19.7 Cr As on 28 March, 2023 | 07:50

What is the P/E ratio of Evoq Remedies ?

The P/E ratio of Evoq Remedies is As on 28 March, 2023 | 07:50

What is the PB ratio of Evoq Remedies ?

The PB ratio of Evoq Remedies is 0.9 As on 28 March, 2023 | 07:50

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number